Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22827973 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Other: placebo;   Other: quality-of-life assessment;   Procedure: questionnaire administration;   Procedure: laboratory biomarker analysis;   Drug: defined green tea catechin extract

Indicates status has not been verified in more than two years